Autologous cells derived from different sources and administered using different regimens for 'no‐option' critical lower limb ischaemia patients New

Autologous cells derived from different sources and administered using different regimens for 'no‐option' critical lower limb ischaemia patients New is a topic covered in the Cochrane Abstracts.

To view the entire topic, please sign in or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics: